scholarly journals Tracking Multifocal Epilepsy With Automated Electric Source Imaging in a Patient With Triple-X Syndrome

2022 ◽  
Vol 18 (1) ◽  
pp. 96
Author(s):  
Markus Gschwind ◽  
Barbora Zima ◽  
Krassen Nedeltchev ◽  
Pieter van Mierlo ◽  
Stephan Rüegg
2020 ◽  
Vol 131 (12) ◽  
pp. 2795-2803
Author(s):  
Bernd J. Vorderwülbecke ◽  
Margherita Carboni ◽  
Sebastien Tourbier ◽  
Denis Brunet ◽  
Martin Seeber ◽  
...  

2008 ◽  
Vol 119 ◽  
pp. S114-S115
Author(s):  
Verena Brodbeck ◽  
Agustina M. Lascano ◽  
Laurent Spinelli ◽  
Margitta Seeck ◽  
Christoph M. Michel

2014 ◽  
Vol 108 (2) ◽  
pp. 267-279 ◽  
Author(s):  
Odysseas Kargiotis ◽  
Agustina M. Lascano ◽  
Valentina Garibotto ◽  
Laurent Spinelli ◽  
Melanie Genetti ◽  
...  

Neurology ◽  
2019 ◽  
Vol 92 (6) ◽  
pp. e576-e586 ◽  
Author(s):  
Lene Duez ◽  
Hatice Tankisi ◽  
Peter Orm Hansen ◽  
Per Sidenius ◽  
Anne Sabers ◽  
...  

ObjectiveTo determine the diagnostic accuracy and clinical utility of electromagnetic source imaging (EMSI) in presurgical evaluation of patients with epilepsy.MethodsWe prospectively recorded magnetoencephalography (MEG) simultaneously with EEG and performed EMSI, comprising electric source imaging, magnetic source imaging, and analysis of combined MEG-EEG datasets, using 2 different software packages. As reference standard for irritative zone (IZ) and seizure onset zone (SOZ), we used intracranial recordings and for localization accuracy, outcome 1 year after operation.ResultsWe included 141 consecutive patients. EMSI showed localized epileptiform discharges in 94 patients (67%). Most of the epileptiform discharge clusters (72%) were identified by both modalities, 15% only by EEG, and 14% only by MEG. Agreement was substantial between inverse solutions and moderate between software packages. EMSI provided new information that changed the management plan in 34% of the patients, and these changes were useful in 80%. Depending on the method, EMSI had a concordance of 53% to 89% with IZ and 35% to 73% with SOZ. Localization accuracy of EMSI was between 44% and 57%, which was not significantly different from MRI (49%–76%) and PET (54%–85%). Combined EMSI achieved significantly higher odds ratio compared to electric source imaging and magnetic source imaging.ConclusionEMSI has accuracy similar to established imaging methods and provides clinically useful, new information in 34% of the patients.Classification of evidenceThis study provides Class IV evidence that EMSI had a concordance of 53%–89% and 35%–73% (depending on analysis) for the localization of epileptic focus as compared with intracranial recordings—IZ and SOZ, respectively.


2019 ◽  
Vol 22 (6) ◽  
pp. 260-267
Author(s):  
Gabriele Schwarz ◽  
Gertraud Puttinger ◽  
Tim J. von Oertzen

Zusammenfassung Epilepsiechirurgie ist eine hochwirksame Therapie mit kurativem Anspruch. Dies belegen inzwischen 3 Studien mit Klasse-1-Evidenz. Bei pharmakoresistenter fokaler Epilepsie mit einer Krankheitsdauer von fast 20 Jahren, mit kürzerer Krankheitsdauer von durchschnittlich 5 Jahren sowie bei Kindern wurde jeweils unabhängig voneinander gezeigt, dass Epilepsiechirurgie dem „best medical treatment“ hochsignifikant überlegen ist. Mithilfe multimodaler Untersuchungsmethoden (z. B. Langzeit-Video-EEG, hochauflösendes cMRT nach Epilepsieprotokoll, FDG-PET, neuropsychologische Testung, fMRT, ev. iktale SPECT-Untersuchung und Verrechnung mittels SISCOM, Postprocessing des cMRTs, „electric source imaging“ [ESI], Magnetenzephalographie [MEG], invasive Abklärung mittels Stereo-EEG-Elektroden oder subduralen Elektroden und WADA-Test) ist es in der prächirurgischen Epilepsiediagnostik nun möglich, Patienten einen epilepsiechirurgischen Eingriff anzubieten, die früher als schlechte oder aussichtslose Kandidaten für eine Epilepsiechirurgie eingeschätzt wurden.


2021 ◽  
Author(s):  
Margherita A.G. Matarrese ◽  
Alessandro Loppini ◽  
Saeed Jahromi ◽  
Eleonora Tamilia ◽  
Lorenzo Fabbri ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document